Analysis of Geographic Areas
Boston Scientific Corp. operates in 2 regions: U.S. and International.
Area Asset Turnover
Boston Scientific Corp., asset turnover by geographic area
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| U.S. | 6.15 | 5.81 | 4.95 | 5.37 | 5.22 |
| International | 4.19 | 4.69 | 4.51 | 4.91 | 5.95 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The asset turnover ratios for the U.S. and International segments exhibit diverging trajectories over the analyzed five-year period. While the U.S. market demonstrates an overall upward trend in asset utilization efficiency, the International segment shows a notable decline in its ability to generate revenue relative to its asset base.
- U.S. Market Efficiency
- The U.S. asset turnover ratio increased from 5.22 in 2018 to 6.15 in 2022. Although a temporary contraction to 4.95 occurred in 2020, the segment experienced a strong recovery in 2021 and 2022. This overall growth indicates an improvement in the productivity of assets deployed within the domestic market.
- International Market Efficiency
- In contrast, the International asset turnover ratio followed a downward trend, falling from 5.95 in 2018 to 4.19 in 2022. A significant reduction in efficiency was observed between 2018 and 2020. Despite a slight recovery to 4.69 in 2021, the ratio reached its lowest point in 2022, signaling a decrease in the revenue-generating capacity of international assets.
- Comparative Geographic Performance
- A reversal in relative efficiency is observed between the two regions. In 2018, the International segment was the more efficient operator with a higher turnover ratio than the U.S. By 2022, this relationship had inverted, with the U.S. segment significantly outperforming the International segment in asset utilization.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Area Asset Turnover: U.S.
Boston Scientific Corp.; U.S.; area asset turnover calculation
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Net sales | 7,632) | 6,911) | 5,701) | 6,167) | 5,538) |
| Property, plant and equipment, net | 1,241) | 1,190) | 1,151) | 1,148) | 1,061) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 6.15 | 5.81 | 4.95 | 5.37 | 5.22 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Area asset turnover = Net sales ÷ Property, plant and equipment, net
= 7,632 ÷ 1,241 = 6.15
The financial performance regarding U.S. operations between 2018 and 2022 demonstrates a strong upward trajectory in asset efficiency and revenue generation. While there was a temporary contraction in 2020, the subsequent recovery and growth indicate an enhanced ability to leverage fixed assets to drive top-line results.
- Net Sales Trends
- Net sales in the U.S. grew from 5,538 million US$ in 2018 to 7,632 million US$ by 2022. A notable decline occurred in 2020, where sales dropped to 5,701 million US$, representing a deviation from the general growth trend. However, this was followed by a robust recovery in 2021 and continued expansion into 2022, marking a total increase of approximately 37.8% over the five-year period.
- Property, Plant and Equipment (PPE) Investment
- Investment in net PPE remained relatively stable with a steady, incremental increase. Assets grew from 1,061 million US$ in 2018 to 1,241 million US$ in 2022. This disciplined growth in the asset base, totaling roughly 17%, suggests that revenue growth was not primarily driven by massive capital expenditures, but rather by increased productivity of existing assets.
- Area Asset Turnover Analysis
- The area asset turnover ratio exhibited an overall positive trend, rising from 5.22 in 2018 to 6.15 in 2022. The ratio dipped to 4.95 in 2020, mirroring the decline in net sales during that period. The subsequent increase to 5.81 in 2021 and 6.15 in 2022 indicates a significant improvement in operational efficiency, as the company generated progressively more revenue per dollar of net PPE.
The divergence between the modest growth in fixed assets and the more aggressive growth in net sales has resulted in a strengthened asset turnover profile. The operational capacity in the U.S. is being utilized more effectively, leading to higher capital efficiency by the end of the analyzed period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Area Asset Turnover: International
Boston Scientific Corp.; International; area asset turnover calculation
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | |||||
| Net sales | 5,051) | 4,977) | 4,212) | 4,568) | 4,286) |
| Property, plant and equipment, net | 1,205) | 1,061) | 933) | 931) | 720) |
| Area Activity Ratio | |||||
| Area asset turnover1 | 4.19 | 4.69 | 4.51 | 4.91 | 5.95 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Area asset turnover = Net sales ÷ Property, plant and equipment, net
= 5,051 ÷ 1,205 = 4.19
A general downward trend is observed in the area asset turnover for international operations between 2018 and 2022. While net sales experienced an overall increase over the period, the rate of growth in property, plant, and equipment significantly outpaced revenue generation, leading to a decline in asset utilization efficiency.
- Net Sales Performance
- International net sales grew from 4,286 million US dollars in 2018 to 5,051 million US dollars in 2022. A temporary contraction occurred in 2020, where sales dropped to 4,212 million US dollars, followed by a strong recovery in 2021 and 2022.
- Capital Investment Trends
- There was a consistent and substantial increase in net property, plant, and equipment, which rose from 720 million US dollars in 2018 to 1,205 million US dollars by the end of 2022. This represents a continuous expansion of the international physical asset base.
- Area Asset Turnover Analysis
- The area asset turnover ratio declined from 5.95 in 2018 to 4.19 in 2022. The ratio reached a mid-period low of 4.51 in 2020 before a slight recovery to 4.69 in 2021 and a further drop in 2022. This trend indicates that each dollar invested in international fixed assets is generating progressively less revenue, as the 67% increase in net property, plant, and equipment exceeded the 18% increase in net sales over the analyzed timeframe.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Property, plant and equipment, net
Boston Scientific Corp., property, plant and equipment, net by geographic area
US$ in millions
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| U.S. | 1,241) | 1,190) | 1,151) | 1,148) | 1,061) |
| International | 1,205) | 1,061) | 933) | 931) | 720) |
| Total | 2,446) | 2,251) | 2,084) | 2,079) | 1,781) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Net property, plant, and equipment experienced a consistent upward trajectory between 2018 and 2022, reflecting a period of sustained capital investment. Total net assets grew from 1,781 million US dollars to 2,446 million US dollars, representing a cumulative increase of approximately 37% over the five-year period.
- Total Asset Growth Trends
- A significant increase was observed between 2018 and 2019, followed by a period of relative stability in 2020. Growth resumed a steady pace in 2021 and 2022, with the total asset base expanding by 8.0% and 8.7% respectively in those final two years.
- U.S. Regional Investment
- Investment in U.S. assets demonstrated a moderate and stable growth pattern. Net assets rose from 1,061 million US dollars in 2018 to 1,241 million US dollars in 2022. This represents a total increase of approximately 17%, with growth remaining steady and incremental throughout the observed period.
- International Regional Expansion
- International assets exhibited more aggressive growth compared to the domestic base. Starting at 720 million US dollars in 2018, international net assets increased to 1,205 million US dollars by 2022, marking a total increase of approximately 67%. A notable surge occurred between 2018 and 2019, where assets grew by nearly 30%.
- Geographic Distribution Shift
- A convergence in the geographic distribution of assets is evident. In 2018, U.S. assets accounted for nearly 60% of the total net property, plant, and equipment. By 2022, this distribution shifted toward a near-equal split, with international assets comprising approximately 49% of the total portfolio, indicating a strategic expansion of the global operational footprint.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Net sales
Boston Scientific Corp., net sales by geographic area
US$ in millions
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | |
|---|---|---|---|---|---|
| U.S. | 7,632) | 6,911) | 5,701) | 6,167) | 5,538) |
| International | 5,051) | 4,977) | 4,212) | 4,568) | 4,286) |
| Total | 12,683) | 11,888) | 9,913) | 10,735) | 9,824) |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
Total net sales exhibited an overall upward trajectory over the five-year period from 2018 to 2022, increasing from 9,824 million to 12,683 million. A temporary contraction occurred in 2020, where total sales declined by approximately 7.6%, before a significant recovery in 2021 and continued growth into 2022.
- United States Market Performance
- The U.S. segment served as the primary driver of revenue growth, rising from 5,538 million in 2018 to 7,632 million in 2022. While the region experienced a dip in 2020 to 5,701 million, the subsequent rebound was aggressive, with a 21.2% increase in 2021 and a further 10.4% increase in 2022. This indicates a strong recovery and sustained demand within the domestic market.
- International Market Performance
- International sales demonstrated more moderate growth and higher volatility relative to the U.S. market. Net sales increased from 4,286 million in 2018 to 5,051 million in 2022. After the 2020 decline to 4,212 million, the international segment recovered to 4,977 million in 2021, but growth slowed significantly in 2022, increasing by only 1.5%.
- Geographic Revenue Concentration
- A progressive shift in revenue concentration toward the U.S. market is observed. The U.S. contribution to total net sales grew from 56.4% in 2018 to 60.1% in 2022. This increasing reliance on the domestic market is highlighted by the disparity in growth rates between 2021 and 2022, where U.S. sales expanded at a much faster pace than international sales.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?